Patents by Inventor Celia O'Brien

Celia O'Brien has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Detection of trophozoites and cysts and protection against infection
    Patent number: 8852596
    Abstract: Immunolocalization of ?- and ?-giardin in Giardia lamblia trophozoites revealed that both giardins are strictly associated with the ventral disc. Optical sectioning of immunolabeled ventral disc, together with quantitative co-localization of ?- and ?-giardin immunoreactivity, demonstrated that ?-giardin is primarily localized to the ventral side, and ?-giardin is localized to the dorsal side of the ventral disc. Antibodies to ?-giardin and ?-giardin can both be used as diagnostic agents; anti-?-giardin antibody can be used as a therapeutic reagent to inhibit binding of trophozoites to host cells.
    Type: Grant
    Filed: October 15, 2012
    Date of Patent: October 7, 2014
    Assignee: The United States of America, as represented by the Secretary of Agriculture
    Inventors: Mark C. Jenkins, Ronald Fayer, Monica Santin, Dumitru Macarisin, Celia O'Brien
  • Vaccine for the prevention of bacterial infection of the bovine mammary gland
    Patent number: 6984381
    Abstract: A novel vaccine for immunizing animals against Staphylococcus aureus-induced mastitis is disclosed. The vaccine is comprised of whole killed cells of S. aureus in a dosage effective to immunize an animal against the organism, in combination with a pharmaceutically acceptable carrier.
    Type: Grant
    Filed: July 5, 2002
    Date of Patent: January 10, 2006
    Assignee: The United States of America as represented by the Secretary of Agriculture
    Inventors: Albert Guidry, Celia O'Brien
  • Vaccine for the prevention of bacterial infection of the bovine mammary gland
    Publication number: 20040028688
    Abstract: A novel vaccine for immunizing animals against Staphylococcus aureus -induced mastitis is disclosed. The vaccine is comprised of whole killed cells of S. aureus in a dosage effective to immunize an animal against the organism, in combination with a pharmaceutically acceptable carrier.
    Type: Application
    Filed: July 5, 2002
    Publication date: February 12, 2004
    Inventors: Albert Guidry, Celia O'Brien